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Background: Despite recommendations by Health Authorities, influenza immunization coverage remains low in
children with chronic diseases. Different medical providers involved in the management of children with chronic
conditions may affect the pattern of influenza vaccine recommendations and coverage. The likelihood of
vaccination by type of provider in children with chronic conditions is poorly understood. Therefore, the objectives
of this study were to analyze the pattern and the effect of recommendations for seasonal influenza immunization
provided by different physician profiles to families of children with chronic diseases and to measure the frequency
of immunization in the study population.
Methods: We recruited children with chronic diseases aged 6 months–18 years who subsequently presented to
specialty clinics for routine follow-up visits, during spring 2009, in three Italian Regions Families of children with
chronic diseases were interviewed during routine visits at reference centers through a face-to-face interview. We
analyzed the following immunization predictors: having received a recommendation toward influenza
immunization by a health provider; child’s sex and age; mothers and fathers’ age; parental education and
employment; underlying child’s disease; number of contacts with health providers in the previous year. Influenza
immunization coverage was calculated as the proportion of children who received at least one dose of seasonal
influenza vaccine in the previous season. We calculated prevalence ratios and we used a generalized linear model
with Poisson family, log link and robust error variance to assess the effect of socio-demographic variables,
underlying diseases, and recommendations provided by physicians on influenza immunization.
Results: We enrolled 275 families of children with chronic diseases. Overall influenza coverage was 57.5%, with a
low of 25% in children with neurological diseases and a high of 91.2% in those with cystic fibrosis. While 10.6% of
children who did not receive any recommendation toward influenza immunization were immunized, among those
who received a recommendation 87.5-94.7% did, depending on the health professional providing the
recommendation. Receiving a recommendation by any provider is a strong predictor of immunization (PR = 8.5 95%
CI 4.6;15.6) Most children received an immunization recommendation by a specialty (25.8%) or a family pediatrician
(23.3%) and were immunized by a family pediatrician (58.7%) or a community vaccinator (55.2%).
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Conclusions: Receiving a specific recommendation by a physician is a strong determinant of being immunized
against seasonal influenza in children with chronic diseases independently of other factors. Heterogeneity exists
among children with different chronic diseases regarding influenza recommendation despite international
guidelines. Increasing the frequency of appropriate recommendations toward influenza immunization by physicians
is a single powerful intervention that may increase coverage in children with chronic conditions.
Keywords: Influenza, Immunization, Chronic disease, Children, Physicians, RecommendationsBackground
Human influenza infection is associated with a high risk of
hospitalization for serious complications in children with
chronic conditions [1,2]. Mechanisms that increase the risk
of influenza complications in children with chronic dis-
eases depend on the specific underlying disease. Children
with neurological disorders show an increased risk of aspir-
ation, and may experience respiratory failure associated
with influenza infection [3,4]. Children affected by cystic fi-
brosis may show pulmonary exacerbations caused by the
influenza virus [5,6]. Diabetic children are prone to meta-
bolic failure during influenza infection [7]. HIV-infected
children and adolescents, especially persons with a low
CD4 cell count or AIDS, can experience more severe com-
plications of seasonal influenza [8]. High rates of influenza-
associated complications and death have been reported in
children with Down syndrome [9].
Most European countries have implemented selective
immunization programs for children with chronic dis-
eases, while in the US influenza immunization is offered
to all children [10].
Although influenza immunization is crucial in children
with chronic medical conditions, as underscored in inter-
national recommendations [10], influenza immunization
coverage in these patients remains low in many European
countries, including Italy [11-14].
Factors that can limit immunization uptake in this
population include difficulty in identifying at-risk children
and poor awareness of specific recommendations by
health professionals [15,16]. Additional reasons reported
for insufficient immunization uptake in this group of chil-
dren include false contraindications and, less frequently, a
reactivation of the underlying disease [16,17].
It is also well recognized that multilevel interventions,
including recommendations to vaccinate provided by phy-
sicians, represent a powerful factor favoring immunization
[18,19]. On the other hand, determinants of influenza
immunization in children affected with chronic diseases
may differ from those of the general healthy population
and have not been sufficiently studied.
In Italy, as in other European countries, influenza vaccine
is recommended and offered free of charge to all children
with chronic conditions [20]. Most Italian children receive
immunizations in public vaccination centers, while someare vaccinated by family pediatricians in their office, or,
when they are affected by a chronic disease, by specialty
pediatricians in reference centers. Hence, influenza
immunization of children affected with chronic diseases
possibly depends on recommendations provided by differ-
ent health providers such as family pediatricians, specialty
pediatricians, and community vaccinators.
In a previous study conducted on families of chil-
dren with chronic diseases we observed insufficient
immunization coverage and a significant delay for
both routine and recommended immunizations [17].
While it is clear that recommendation for influenza vac-
cination by a health care provider is a strong predictor of
vaccination, the likelihood of vaccination by type of pro-
vider in children with chronic conditions is poorly under-
stood. Therefore, the objectives of this study were to
analyze the pattern and the effect of recommendations for
seasonal influenza immunization provided by different
physician profiles to families of children with chronic dis-
eases and to measure the frequency of immunization in
the study population.
Methods
Study design and sample selection
We recruited children affected with chronic diseases
aged 6 months–18 years who subsequently presented to
specialty clinics for routine follow-up visits, during
spring 2009, in three Italian Regions. All enrolled
patients were in the routine care of the specialty clinics.
The population served by the three Regions is of ap-
proximately 13.000.000 people and represents nearly
22% of the Italian population overall. The three Regions
were selected to represent three geographic areas of Italy
(North, Center and South), in order to account for geo-
graphical trends. In the three Regions included in the
study the number of children 6 months-18 years old
affected with any chronic disease is approximately
120.000. The number of children affected with the
chronic diseases considered in the study referring to the
participating specialty clinics is nearly 5.000.
Eligibility criteria included signing an informed consent
by parents and having one of the following conditions:
type 1 diabetes, cystic fibrosis, Down syndrome, HIV in-
fection, or a neurological disease including neurological
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other diseases associated with seizures, neuromuscular
disease, encephalopathy, genetic diseases with neuro-
logical impairment, hydrocephalus).
We chose to consider these conditions because they
represent a wide spectrum of chronic diseases in terms
of morbidity, mortality and pattern of contacts with
different health providers, and because they experience
frequent complications during influenza [4-9]. Moreover
the selected study population includes children affected
with diseases that may be perceived with different levels
of severity: this may affect the frequency of recommenda-
tions and immunization coverage. The children’s diagno-
ses were confirmed by the reference centers in charge of
following these patients. The study was approved by the
ethical committee of the Bambino Gesù Children’s
Hospital, Rome, Italy.
Enrollment, data collection and statistical analysis
Families of children with chronic diseases were inter-
viewed during routine visits at reference centers. One
interviewer visited each specialty clinic once a week for
three months during visit hours, and performed a face-
to-face interview with parents of children affected with
chronic diseases who attended the clinic. All the families
of patients who presented during the day in which the
interviewer was on duty at the Center were recruited.
Since appointments for these visits were programmed,
families were requested to bring proof of the child’s
vaccinations in order to review and record the child’s
vaccination history. Families that had not brought their
child’s immunization card were not enrolled in the
study. Interviews were conducted through a standar-
dized questionnaire collecting information regarding
the child's vaccination history, recommendation
received by type of provider, and barriers encountered
by parents to completing immunizations in a timely
manner. Information on socio-demographic characteris-
tics, type of underlying disease, and contacts with health
providers in the previous year were also recorded.
Immunization coverage was calculated as the pro-
portion of children who received at least one dose of
seasonal influenza vaccine in the previous season on
the total number of children. Confidence intervals of
proportions were calculated as 95% interval. Differences
in proportions were evaluated through the Chi square
test whereas differences between means were analyzed
through the ANOVA F test or the Kruskal-Wallis test.
We calculated prevalence ratios and we used a generalized
linear model with Poisson family, log link and robust error
variance to assess the effect of socio-demographic vari-
ables, underlying diseases, and recommendations provided
by physicians on influenza immunization [21]. We consid-
ered the following immunization predictors: child’s sex(reference: females) and age; parental age; parental educa-
tion level (high school diploma or higher vs lower levels);
parental employment status; child’s underlying disease
(reference: neurological diseases); recommendation
received by a health provider; number of visits by health
provider in the last year. Number of visits was treated as a
continuous variable. Independent variables included in the
multivariate analysis were selected among those associated
with influenza immunization with a p < 0.20 at the uni-
variate analysis. Crude and adjusted prevalence ratios and
their 95% confidence intervals were used as measures of
effect. Software STATA 10 was used to analyze data.
A tree graph was used for describing the path that
families of children with chronic diseases followed, from
the moment they received the influenza vaccine recom-
mendations to the administration of the vaccine by type
of health provider.Results
We enrolled 275 children, whose socio-demographic
characteristics are shown in Table 1.
None of the families eligible for the study declined
participation. The mean age of participants was 8.6 years.
A proportion of 46% were females. Mothers’ and fathers’
ages were similar across the groups with different condi-
tions. Patients with HIV infection were more likely for-
eigners, had parents with a lower education level, and
their fathers were more likely unemployed, compared
with patients affected with other diseases. The average
number of visits differed by health provider, being high-
est for specialty pediatricians, and lowest for community
vaccinators, although children with Down syndrome and
neurological diseases had frequent contacts with family
pediatricians.
Children affected by cystic fibrosis and HIV infection
were more frequently recommended to receive influenza
immunization compared to patients with other chronic
diseases (Table 2). Children with cystic fibrosis and HIV
infection received influenza vaccination recommenda-
tions mainly from specialty pediatricians, while children
affected with other diseases were more frequently recom-
mended toward immunization by family pediatricians
(Table 2). Fewer families reported receiving an influenza
recommendation from community vaccinators. However
it should be considered that contacts with specialty
pediatricians and family pediatricians were frequent,
while contacts with community vaccinators were rare.
The overall influenza coverage was 57.5%, with a low
of 25% in children with neurological diseases and a high
of 91.2% in those affected with cystic fibrosis (Table 3).
Children who did not receive a recommendation toward
influenza immunization had the lowest coverage. Although
the pattern of recommendations differed by disease group,












N = 57 N = 52 N = 70 N = 36 N = 60 N = 275
Age, years; mean (SD) 9.5 (4.9) 10.3 (3.9) 5.5 (3.9) 10.4 (4.0) 8.8 (5.0) 8.6 (4.8) <0.01 a
Females; N (%) 23 (40.4) 23 (44.2) 37 (52.9) 21 (58.3) 22 (36.7) 126 (45.8) 0.17 b
Foreigners; n (%) 2 (3.5) 0 2 (2.9) 4 (11.1) 0 8 (2.9) 0.02 b
Mother’s age, years; mean (SD) 39.2 (6.5) 41.8 (4.9) 40.9 (6.5) 40.1 (9.7) 38.8 (6.9) 40.1 (6.8) 0.11 c
Father’s age, years; mean (SD) 42.9 (6.4) 44.7 (5.3) 43.0 (6.9) 43.5 (7.9) 41.9 (6.6) 43.1 (6.6) 0.25 c
Mothers with at least high school diploma; N (%) 40 (70.2) 30 (57.7) 48 (68.6) 5 (20.0) 32 (54.2) 155 (58.9) <0.01 b
Employed mothers; N (%) 23 (40.3) 33(63.5) 35 (50.0) 8 (30.8) 19 (31.7) 118 (44.5) <0.01 b
Fathers with at least high school diploma; N (%) 32 (56.1) 26 (53.1) 43 (64.2) 3 (15.8) 33 (56.9) 137 (54.8) <0.01 b
Employed fathers; N (%) 54 (94.7) 46 (92.0) 65 (95.6) 14 (70.0) 55 (94.8) 234 (92.5) <0.01 b
Number of visits by specialty pediatrician in the last year;
mean (SD)
4.5 (1.3) 4.5 (1.5) 2.9 (2.0) 5.9 (0.6) 3.9 (1.3) 4.1 (1.7) <0.01 a
Number of visits by family pediatrician in the last year;
mean (SD)
2.9 (2.3) 3.6 (2.0) 4.4 (1.7) 2.4 (2.3) 4.5 (1.7) 3.7 (2.1) <0.01 a
Number of visits by community vaccinators in the last year;
mean (SD)
0.6 (0.9) 0.3 (0.5) 0.8 (1.3) 0.3 (0.5) 0.5 (1.1) 0.5 [1] 0.26 a
Notes:
a) Kruskal-Wallis test.
b) Chi squared test.
c) Anova F-test.
Missing values range: 1–17.
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in a high rate in all categories.
Since children included had different recommendation
patterns, we reviewed their path from recommendation
to receipt of influenza vaccine. We observed that the
most frequent immunization path was receiving a
recommendation to be immunized by a specialty or a
family pediatrician and then being immunized by a fam-
ily pediatrician or a community vaccinator (Figure 1).
Specialty pediatricians rarely administered the influenza
vaccine.
Since the effect of a recommendation received by a




Cystic fibrosis Type 1 Diabetes Down Synd
N = 57 N = 52 N = 70
Specialty pediatrician 27/57 7/52 3/70
47.4 (34.0 - 60.7) 13.5 (3.9 - 23.1) 4.3 (0.0 - 9.1
Family pediatrician 12/57 16/52 26/70
21.1 (10.1 - 32.0) 30.8 (17.8 - 43.7) 37.1 (25.5 -
Community vaccinators 3/57 1/52 3/70
5.3 (0.0 - 11.2) 1.9 (0.0 - 5.7) 4.3 (0.0 - 9.1
Two or more physicians 9/57 5/52 2/70
15.8 (6.0 - 25.6) 9.6 (1.3 - 17.9) 2.9 (0.0 - 6.9
No recommendation 6/57 23/52 36/70
10.5 (2.3 - 18.7) 44.2 (30.3 - 58.2) 51.4 (39.4 -we applied a multivariate analysis showing that receiving
a recommendation by any physician is a strong predictor
of being vaccinated against seasonal influenza independ-
ently of other variables (PR = 8.5 95% CI 4.6;15.5). In
fact, children who received a specific recommendation
to receive influenza immunization by one of the three
providers considered were significantly more likely to be
vaccinated than those who did not receive any recom-
mendation (Table 4). The prevalence ratio of being
immunized by recommendation of different health pro-
viders was homogeneous and did not differ if a child
received a recommendation by more than one health
provider. None of the other potential determinants ofunization by health provider and disease; proportion
rome HIV infection Neurological
disease
Total p
N = 36 N = 60 N = 275
31/36 3/60 71/275 <0,001
) 86.1 (74.2 - 98.0) 5.0 (0.0 - 10.7) 25.82 (20.6 - 31.0)
0/36 10/60 64/275 <0,001
48.7) 0.0 (0.0 - 0.0) 16.7 (7.0 - 26.4) 23.3 (18.2 - 28.3)
0/36 1/60 8/275 <0,001
) 0.0 (0.0 - 0.0) 1.7 (0.0 - 5.0) 2.9 (0.9 - 4.9)
2/36 1/60 19/275 <0,001
) 5.6 (0.0 - 13.4) 1.7 (0.0 - 5.0) 6.9 (3.9 - 9.9)
3/36 45/60 113/275 <0,001
63.4) 8.3 (0.0 - 17.8) 75.0 (63.7 - 86.3) 41.1 (35.2 - 46.9)
Table 3 Immunization coverage by provider recommendation and disease; proportion
Recommendation
provided by







N = 57 N = 52 N = 70 N = 36 N = 60 N = 275
Specialty pediatrician 26/27 (96.3%) 7/7 (100%) 3/3 (100%) 24/31 (77.4%) 3/3 (100%) 63/71 (88.7%) <0.001
Family pediatrician 11/12 (91.7%) 14/16 (87.5%) 24/26 (92.3%) 0 9/10 (90%) 58/64 (90.6%) <0.001
Community vaccinators 3/3 (100%) 1/1 (100%) 2/3 (66.7%) 0 1/1 (100%) 7/8 (87.5%) <0.001
Two or more physicians 9/9 (100%) 5/5 (100%) 2/2 (100%) 1/2 (50%) 1/1 (100%) 18/19 (94.7%) <0.001
No recommendation 3/6 (50%) 3/23 (13%) 5/36 (13.9%) 0 1/45 (2.2%) 12/113 (10.6%) <0.001
Total coverage 52/57 (91.2%) 30/52 (57.7%) 36/70 (51.4%) 25/36 (69.4%) 15/60 (25%) 158/275 (57.5%) <0.001
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associated with influenza uptake (Table 4).
Discussion
Our study shows that receiving a specific recommenda-
tion for influenza immunization by any physician is a
single strong determinant of influenza immunization
uptake in children with chronic diseases. This positive
influence is independent from socio-demographic char-
acteristics, number of contacts with health providers,
and underlying disease.
We found that immunization coverage in children
with chronic conditions substantially changes depending
on the underlying disease, as already observed [22], des-
pite all participants in the study belonged to categories
addressed by international guidelines on influenza
immunization [23]. Patients with neurological disorders
had the lowest immunization coverage and they were
those with the lowest recommendation level. This finding
might be explained by different perceptions of influenza
infection severity in different chronic conditions by
health professionals, as observed for neurological disor-
ders and type 1 diabetes in other studies [24,25].
Many studies focused on barriers to immunization and
on multilevel interventions to increase vaccinationFigure 1 Illustrates the path that children followed from immunizatio
the most frequent path for each of the resulting categories.coverage in healthy and chronic patients [26]. Strong sci-
entific evidence exists showing that multicomponent
interventions including education are effective in im-
proving immunization coverage [19]. Physicians willing-
ness and capabilities to recommend vaccinations are
affected by the perceived relevance of the vaccines, by
knowledge on their contraindications, by the health care
system organization, and by communication between
providers [26,27]. Also non-integrated interventions may
be effective in improving immunization coverage in chil-
dren with chronic conditions, but the evidence is weak
[19]. Multicomponent interventions including reminder
systems or other educational initiatives were not in place
in our setting. Increasing the ability to provide a recom-
mendation toward immunization by physicians may
represent therefore a simple and efficacious strategy in
settings where multicomponent interventions are not
in place.
Different health providers are involved in the manage-
ment of children with chronic conditions and multiple
contacts with different specialists may result in different
paths from recommendation to vaccine administration.
We focused on the health providers that most frequently
are in contact with these children in the Italian setting
and whose recommendation may influence their decisionn recommendation to immunization uptake. Thicker lines represent
Table 4 Determinants of influenza immunization; multivariate analysis
Univariate analysis Multivariate analysis
Determinant PR (95% CI) p PR (95% CI) p
Child's age (continuous) 1.0 (0.98 - 1.03) 0.588
Child male gender 0.9 (0.8 – 1.1) 0.523
Mother's age (continuous) 1.0 (0.99 – 1.02) 0.448
Father's age (continuous) 1.0 (0.99 – 1.03) 0.165 1.0 (0.99 – 1.0) 0.851
Mother with at least high school diploma 1.2 (1.0 – 1.5) 0.105 1.0 (0.9 – 1.2) 0.682
Father with at least high school diploma 1.0 (0.8 – 1.2) 0.815
Mother employed 1.1 (0.9 – 1.4) 0.292
Father employed 1.1 (0.7 – 1.7) 0.708
Neurological diseases (reference)
Diabetes 2.3 (1.4 – 3.8) 0.001 1.3 (1.0 – 1.8) 0.099
Cystic fibrosis 3.6 (2.3 – 5.7) <0.001 1.3 (1.0 – 1.8) 0.080
HIV infection 2.8 (1.7 – 4.5) <0.001 1.0 (0.7 – 1.5) 0.837
Down syndrome 2.1 (1.3 – 3.4) 0.004
No recommendation (reference)
Recommendation by specialty pediatrician 8.4 (4.9 – 14.4) <0.001 8.4 (4.5 – 15.7) <0.001
Recommendation by family pediatrician 8.5 (5.0 – 14.7) <0.001 8.6 (4.7 – 15,6) <0.001
Recommendation by community vaccinator 8.2 (4.5 – 15.0) <0.001 7.9 (4.1 – 15.0) <0.001
Recommendation by two or more physicians 8.9 (5.2 – 15.4) <0.001 8.8 (4.7 – 16.2) <0.001
Number of visits by specialty pediatrician (continuous) 1.1 (1.0 – 1.1) 0.032 1.0 (0.95 – 1.04) 0.940
Number of visits by family pediatrician (continuous) 0.9 (0.9 – 1.0) 0.011 1.0 (0.9 – 1.0) 0.109
Number of visits by community vaccinator (continuous) 0.9 (0.8 – 1.0) 0.034 1.0 (0.9 – 1.0) 0.273
Due to missing values, the total number of subjects included in the multivariate model is 250.
PR = Prevalence Ratio.
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received a recommendation by any health provider is
associated with an increased likelihood of receiving influ-
enza immunization. Since health professionals included
in our analysis may provide recommendation and admin-
ister influenza vaccines as well, we investigated the path
from recommendation to vaccination administration that
these children followed. Although the number of visits
by a certain provider is not associated with immunization
uptake, families of patients with chronic diseases refer
most frequently to specialty and family pediatricians.
Given that recommendation to immunize is highly effect-
ive, increasing the frequency of recommendation by
health providers may substantially change immunization
uptake.
This study had several strengths and limitations. We
did not select a sample of clinics in each Region but we
rather selected the largest Reference Centers for the
chronic diseases considered in the study. Although our
study was conducted on a heterogeneous population of
children with different chronic diseases whose informa-
tion on immunization was carefully reviewed, it is likely
that we selected families with a high level of attention to
their child’s disease. It must be underlined that the
follow up for chronic diseases is entirely free of charge inthe Italian health care system and usually large reference
centres concentrate the largest population of children
with chronic diseases in their catchment area. Moreover,
it is of note that families frequently reported having
received a recommendation to immunize against influ-
enza by different health providers, and that the effect of
these recommendations is strong as well. Although we
allowed participation in the study only to families who
brought in their immunization card, we do not feel that
this may have led to a significant bias since their number
was negligible. Patients in charge to reference centers
enrolled in the study were strictly monitored for at
least six months and they were reminded to bring in
their immunization card at each appointment.
We included in the study only a group of chronic
disease that we believe representative but we excluded
some common diseases such as asthma. While asthma
is the most common chronic condition in childhood
for which influenza vaccine is recommended, we felt it
would deserve a specific study to investigate determi-
nants of influenza immunization.
Finally, we might have interviewed, in each health care
centers, patients routinely visited by a single physician,
whose behavior may not reflect the behavior of the en-
tire team of physicians in the same clinic. However, the
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number of physicians on duty, with a high turnover;
moreover, we performed our weekly interviews in differ-
ent weekdays, reducing the probability of meeting
patients referring to the same physician.
Since information on recommendation was collected
through interviews, this may be subject to recall bias and
those who received influenza immunization may better
recall having received a recommendation. However,
although reporting bias is probable, it is unlikely that
such a strong association is explained by these biases,
and, therefore we believe that medical recommenda-
tions are essential to improve immunization coverage.
Finally, we cannot say if our results are applicable to
other countries and settings. However, since the number
of health providers in contact with families of children
with chronic diseases is high, it may well be that recom-
mendation toward influenza immunization may be pro-
vided at multiple levels in other settings. Hence, similar
studies should be conducted in other settings for con-
firming the results.
Conclusions
Our study suggests that increasing the frequency of
recommendations to receive influenza immunization by
health professionals most frequently in contact with chil-
dren with chronic diseases is a single intervention that
may significantly increase influenza immunization cover-
age in settings where other multilevel interventions to
favor immunization are not in place. Public health
actions including education of different health care pro-
viders and improvement of communication to patients
should be pursued to achieve a higher influenza vaccine
coverage in children at risk, as well to enhance the
interventions.
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